Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	lysine-acetylated histone binding	BRD4 ZMYND8 BRD3 TAF1	2.32e-06	30	63	4	GO:0070577
GeneOntologyMolecularFunction	acetylation-dependent protein binding	BRD4 ZMYND8 BRD3 TAF1	2.66e-06	31	63	4	GO:0140033
GeneOntologyMolecularFunction	transcription factor binding	MED6 TCERG1 PCLO ANKRD1 ZMYND8 TAF1 SPEN HSPA4 MED12 DNMT1	1.15e-04	753	63	10	GO:0008134
GeneOntologyMolecularFunction	catalytic activity, acting on DNA	LIG1 WAPL RECQL5 RSF1 TOP1 DNMT1	1.75e-04	262	63	6	GO:0140097
GeneOntologyMolecularFunction	histone binding	BRD4 ZMYND8 RSF1 NAP1L3 BRD3 TAF1	1.86e-04	265	63	6	GO:0042393
GeneOntologyMolecularFunction	RNA polymerase II-specific DNA-binding transcription factor binding	TCERG1 ANKRD1 TAF1 SPEN HSPA4 MED12 DNMT1	3.33e-04	417	63	7	GO:0061629
GeneOntologyMolecularFunction	DNA-binding transcription factor binding	TCERG1 ANKRD1 ZMYND8 TAF1 SPEN HSPA4 MED12 DNMT1	4.69e-04	582	63	8	GO:0140297
GeneOntologyMolecularFunction	ATP-dependent activity	ABCF1 WAPL HSPH1 RECQL5 RSF1 HELZ HSPA4 KIF3A	6.67e-04	614	63	8	GO:0140657
GeneOntologyMolecularFunction	adenyl-nucleotide exchange factor activity	HSPH1 HSPA4	1.00e-03	15	63	2	GO:0000774
GeneOntologyMolecularFunction	RNA polymerase binding	TCERG1 BRD4 RECQL5	1.14e-03	65	63	3	GO:0070063
GeneOntologyMolecularFunction	basal RNA polymerase II transcription machinery binding	BRD4 RECQL5 TAF1	1.19e-03	66	63	3	GO:0001099
GeneOntologyMolecularFunction	basal transcription machinery binding	BRD4 RECQL5 TAF1	1.19e-03	66	63	3	GO:0001098
GeneOntologyMolecularFunction	protein folding chaperone	CLGN HSPH1 HSPA4	1.59e-03	73	63	3	GO:0044183
GeneOntologyMolecularFunction	p53 binding	BRD4 ANKRD1 TAF1	1.85e-03	77	63	3	GO:0002039
GeneOntologyMolecularFunction	transcription coregulator activity	MED6 TCERG1 BRD4 ANKRD1 ZMYND8 SPEN MED12	1.91e-03	562	63	7	GO:0003712
GeneOntologyMolecularFunction	chromatin binding	BRD4 NAP1L3 BRD3 TAF1 SARNP TOP1 MED12 DNMT1	2.17e-03	739	63	8	GO:0003682
GeneOntologyMolecularFunction	transcription coactivator activity	MED6 TCERG1 BRD4 ANKRD1 MED12	2.67e-03	303	63	5	GO:0003713
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	NEFH MED6 TCERG1 BRD4 ANKRD1 ZMYND8 BRD3 SPEN TRDN MED12	3.23e-03	1160	63	10	GO:0030674
GeneOntologyBiologicalProcess	regulation of transcription elongation by RNA polymerase II	MED6 TCERG1 BRD4 RECQL5 ZMYND8	8.15e-06	93	61	5	GO:0034243
GeneOntologyBiologicalProcess	regulation of DNA-templated transcription elongation	MED6 TCERG1 BRD4 RECQL5 ZMYND8	1.47e-05	105	61	5	GO:0032784
GeneOntologyBiologicalProcess	positive regulation of transcription elongation by RNA polymerase II	MED6 TCERG1 BRD4 ZMYND8	1.96e-05	54	61	4	GO:0032968
GeneOntologyBiologicalProcess	positive regulation of DNA-templated transcription, elongation	MED6 TCERG1 BRD4 ZMYND8	3.40e-05	62	61	4	GO:0032786
GeneOntologyBiologicalProcess	transcription elongation by RNA polymerase II	MED6 TCERG1 BRD4 RECQL5 ZMYND8	3.69e-05	127	61	5	GO:0006368
GeneOntologyBiologicalProcess	DNA-templated transcription elongation	MED6 TCERG1 BRD4 RECQL5 ZMYND8	6.72e-05	144	61	5	GO:0006354
Domain	Bromodomain	BRD4 ZMYND8 BRD3 TAF1	7.96e-06	38	63	4	PF00439
Domain	BROMODOMAIN_2	BRD4 ZMYND8 BRD3 TAF1	1.08e-05	41	63	4	PS50014
Domain	BROMO	BRD4 ZMYND8 BRD3 TAF1	1.19e-05	42	63	4	SM00297
Domain	Bromodomain	BRD4 ZMYND8 BRD3 TAF1	1.19e-05	42	63	4	IPR001487
Domain	-	BRD4 ZMYND8 BRD3 TAF1	1.19e-05	42	63	4	1.20.920.10
Domain	BAT2_N	PRRC2C PRRC2B	3.35e-05	3	63	2	PF07001
Domain	BAT2_N	PRRC2C PRRC2B	3.35e-05	3	63	2	IPR009738
Domain	PRRC2	PRRC2C PRRC2B	3.35e-05	3	63	2	IPR033184
Domain	BET	BRD4 BRD3	6.69e-05	4	63	2	PF17035
Domain	NET_dom	BRD4 BRD3	6.69e-05	4	63	2	IPR027353
Domain	NET	BRD4 BRD3	6.69e-05	4	63	2	PS51525
Domain	Bromodomain_CS	BRD4 BRD3 TAF1	9.00e-05	26	63	3	IPR018359
Domain	ZnF_U1	ZMAT2 ZFHX3 SF3A2	1.26e-04	29	63	3	SM00451
Domain	Znf_U1	ZMAT2 ZFHX3 SF3A2	1.26e-04	29	63	3	IPR003604
Domain	-	RBM27 RBM6 UPF3A SPEN GRSF1 RCAN2	1.70e-04	244	63	6	3.30.70.330
Domain	Nucleotide-bd_a/b_plait	RBM27 RBM6 UPF3A SPEN GRSF1 RCAN2	2.30e-04	258	63	6	IPR012677
Domain	BROMODOMAIN_1	BRD4 BRD3 TAF1	2.62e-04	37	63	3	PS00633
Domain	-	HSPH1 HSPA4	7.23e-04	12	63	2	2.60.34.10
Domain	HSP70_peptide-bd	HSPH1 HSPA4	7.23e-04	12	63	2	IPR029047
Domain	-	HSPH1 HSPA4	8.53e-04	13	63	2	1.20.1270.10
Domain	Heat_shock_70_CS	HSPH1 HSPA4	8.53e-04	13	63	2	IPR018181
Domain	HSP70_C	HSPH1 HSPA4	8.53e-04	13	63	2	IPR029048
Domain	HSP70	HSPH1 HSPA4	1.30e-03	16	63	2	PF00012
Domain	HSP70_2	HSPH1 HSPA4	1.47e-03	17	63	2	PS00329
Domain	HSP70_3	HSPH1 HSPA4	1.47e-03	17	63	2	PS01036
Domain	HSP70_1	HSPH1 HSPA4	1.47e-03	17	63	2	PS00297
Domain	ZF_MATRIN	ZMAT2 SF3A2	1.65e-03	18	63	2	PS50171
Domain	Hsp_70_fam	HSPH1 HSPA4	1.65e-03	18	63	2	IPR013126
Domain	RRM	RBM27 RBM6 SPEN GRSF1	6.18e-03	217	63	4	SM00360
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	PPP4R3B LIG1 MED6 ABCF1 TCERG1 MYCBP2 RBM27 PRRC2C BRD4 ZMAT2 HSPH1 ZMYND8 PSME1 SARNP SPEN HSPA4 TOP1 SF3A2 MED12 PRRC2B DNMT1	2.17e-16	1103	63	21	34189442
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	SLK ABCF1 WAPL TCERG1 RBM27 RBBP6 PRRC2C ZMAT2 HSPH1 ZMYND8 RSF1 HELZ PRR14L HSPA4 TOP1 PDLIM5 PRRC2B DNMT1 RPL17	2.39e-15	934	63	19	33916271
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	PPP4R3B BROX MED6 WAPL TCERG1 RBM27 RBBP6 BRD4 ZMYND8 RSF1 BRD3 TAF1 PSME1 EIF3J SARNP TOP1 SF3A2 MED12 DNMT1	1.05e-14	1014	63	19	32416067
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	WAPL TCERG1 SLC4A1AP RBM27 RBBP6 PRRC2C BRD4 ZMAT2 RECQL5 ZMYND8 RSF1 RBM6 TAF1 SARNP SPEN TOP1 DNMT1 RPL17	5.35e-14	954	63	18	36373674
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	MED6 ABCF1 TCERG1 SLC4A1AP RBM27 RBBP6 HSPH1 RECQL5 ZMYND8 RBM6 HELZ ZFHX3 BRD3 CTNNA2 EIF3J MAP7 ZHX2 SPEN GRSF1 SF3A2 MED12	8.73e-14	1497	63	21	31527615
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	WAPL TCERG1 RBM27 RBBP6 BRD4 ZMYND8 ZFHX3 TAF1 SARNP SPEN TOP1 DNMT1	1.23e-13	283	63	12	30585729
Pubmed	Human transcription factor protein interaction networks.	SLK TCERG1 RBM27 RBBP6 PRRC2C HSPH1 RECQL5 ZMYND8 RBM6 HELZ ZFHX3 GIGYF1 TAF1 MAP7 ZHX2 SPEN SMAP2 HSPA4 TOP1 PRRC2B	4.12e-13	1429	63	20	35140242
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	SLK WAPL TCERG1 MYCBP2 RBM27 RBBP6 PRRC2C BRD4 TAF1 SPEN MED12 PDLIM5 PRRC2B DNMT1	9.32e-13	549	63	14	38280479
Pubmed	NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.	RBBP6 BRD4 ZMYND8 RSF1 ZFHX3 BRD3 SPEN TOP1	1.52e-11	103	63	8	32744500
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	ABCF1 TCERG1 MYCBP2 RBM27 RBBP6 BRD4 ZMYND8 RBM6 BRD3 UPF3A SARNP SPEN TOP1 SF3A2 MED12 RPL17	6.41e-11	1082	63	16	38697112
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	PPP4R3B LIG1 ABCF1 RBM27 RBBP6 HSPH1 RSF1 RBM6 GIGYF1 EIF3J MAP7 SPEN	1.01e-10	503	63	12	16964243
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	MED6 SLK MYCBP2 RBM27 ZMAT2 RECQL5 RSF1 BRD3 MAP7 SPEN MED12 PDLIM5 KIF3A	1.22e-10	645	63	13	25281560
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	ABCF1 TCERG1 RBM27 RBBP6 PRRC2C RBM6 HELZ SARNP SPEN GRSF1 TOP1 SF3A2 PRRC2B RPL17	1.53e-10	807	63	14	22681889
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	ABCF1 CEP78 TCERG1 BRD4 ZMYND8 RSF1 BRD3 TAF1 SARNP TOP1 DNMT1 RPL17	1.95e-10	533	63	12	30554943
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	SLK CEP78 MYCBP2 RBM27 PRRC2C ZMAT2 HSPH1 HELZ SPEN SMAP2 TOP1 PDLIM5 PRRC2B	4.99e-10	724	63	13	36232890
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	PPP4R3B ABCF1 WAPL TCERG1 MYCBP2 HSPH1 ZMYND8 NGEF NAP1L3 TAF1 PSME1 TOP1 SF3A2 PDLIM5 KIF3A DNMT1	7.84e-10	1285	63	16	35914814
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	ABCF1 CEP78 TCERG1 MYCBP2 RBM27 RBBP6 PRRC2C RBM6 SARNP GRSF1 TOP1 MED12 DNMT1	8.83e-10	759	63	13	35915203
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	SLK MYCBP2 RBBP6 PRRC2C HSPH1 CTNNA2 PSME1 MAP7 SARNP HSPA4 GRSF1 TOP1 SF3A2 PRRC2B DNMT1 RPL17	8.96e-10	1297	63	16	33545068
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	LIG1 ABCF1 WAPL MYCBP2 SLC4A1AP RBBP6 BRD4 ZMYND8 RBM6 HELZ BRD3 SPEN DNMT1	1.12e-09	774	63	13	15302935
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	PPP4R3B LIG1 ABCF1 WAPL TCERG1 RBM27 RBBP6 HSPH1 ZMYND8 HELZ HSPA4 GRSF1 TOP1 SF3A2 DNMT1 RPL17	1.13e-09	1318	63	16	30463901
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	SLK ABCF1 TCERG1 MYCBP2 RBM27 PRRC2C HSPH1 PSME1 EIF3J MAP7 SARNP HSPA4 TOP1 PDLIM5 RPL17	1.54e-09	1149	63	15	35446349
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	ABCF1 MYCBP2 PRRC2C RSF1 RBM6 HELZ SPEN HSPA4 TOP1 MED12 PRRC2B DNMT1	1.93e-09	653	63	12	22586326
Pubmed	Oct4 links multiple epigenetic pathways to the pluripotency network.	WAPL TCERG1 BRD4 HELZ BRD3 TAF1 SF3A2 PRRC2B	3.45e-09	203	63	8	22083510
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	CACNA1A NEFH SLK ABCF1 PRRC2C PCLO HSPH1 NGEF CTNNA2 MAP7 HSPA4 TOP1 PDLIM5 PRRC2B KIF3A RPL17	3.66e-09	1431	63	16	37142655
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	PPP4R3B TCERG1 RBBP6 PRRC2C ZMAT2 RECQL5 RBM6 HELZ MAP7 SPEN PRRC2B	8.17e-09	588	63	11	38580884
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	LIG1 RBBP6 PRRC2C BRD4 ZMAT2 RSF1 BRD3 EIF3J SPEN DNMT1	1.22e-08	469	63	10	27634302
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	CACNA1A TCERG1 PRRC2C NGEF EIF3J HSPA4 TOP1 PRRC2B KIF3A DNMT1	1.38e-08	475	63	10	31040226
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	LIG1 WAPL TCERG1 SLC4A1AP RBM27 ANKRD1 HSPH1 RBM6 HSPA4 TOP1 SF3A2 DNMT1 RPL17	2.07e-08	989	63	13	36424410
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	SLK ABCF1 SLC16A3 TCERG1 SLC4A1AP PRRC2C HSPH1 PSME1 EIF3J MAP7 HSPA4 GRSF1 TOP1 DNMT1 RPL17	2.50e-08	1415	63	15	28515276
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	MED6 WAPL RBM27 BRD4 ZMYND8 TAF1 MED12 PRRC2B	3.01e-08	268	63	8	33640491
Pubmed	Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.	TCERG1 SLC4A1AP RBBP6 PRRC2C BRD4 ZHX2 SARNP SF3A2 PDLIM5	4.31e-08	399	63	9	35987950
Pubmed	Optimized fragmentation schemes and data analysis strategies for proteome-wide cross-link identification.	NEFH LIG1 WAPL HSPH1 PSME1 SARNP HSPA4 TOP1 SF3A2 RPL17	4.43e-08	538	63	10	28524877
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	MED6 TCERG1 RBM27 RBBP6 BRD4 RECQL5 ZMYND8 BRD3 MAP7 SPEN TOP1 SF3A2 DNMT1 RPL17	6.17e-08	1294	63	14	30804502
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	WAPL RBBP6 BRD4 ZMYND8 RSF1 HELZ ZFHX3 BRD3 GIGYF1 TAF1 MAP7 TOP1 PRRC2B	8.43e-08	1116	63	13	31753913
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	PPP4R3B ABCF1 WAPL MYCBP2 RBM27 RBM6 SARNP HSPA4 RPL17	9.90e-08	440	63	9	34244565
Pubmed	Targeted and Interactome Proteomics Revealed the Role of PHD2 in Regulating BRD4 Proline Hydroxylation.	ABCF1 TCERG1 BRD4 RSF1 SARNP HSPA4 TOP1 DNMT1 RPL17	1.01e-07	441	63	9	31239290
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	ABCF1 WAPL TCERG1 MYCBP2 HSPH1 RECQL5 RSF1 PRR14L HSPA4 GRSF1 TOP1 MED12 DNMT1 RPL17	1.07e-07	1353	63	14	29467282
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	WAPL SLC4A1AP BRD4 RECQL5 RSF1 BRD3 TAF1 SPEN TOP1 DNMT1	1.38e-07	608	63	10	36089195
Pubmed	Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery.	PRRC2C HSPH1 HELZ HSPA4 GRSF1 TOP1 RPL17	1.65e-07	223	63	7	20020773
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	SLK ABCF1 WAPL CEP78 TCERG1 PRRC2C HELZ GIGYF1 PRRC2B DNMT1	2.54e-07	650	63	10	38777146
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	SLK ABCF1 RBM27 RBBP6 RSF1 EIF3J MAP7 GRSF1 SF3A2 DNMT1	2.65e-07	653	63	10	33742100
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	MED6 ABCF1 RBBP6 HSPH1 UPF3A EIF3J HSPA4 TOP1 SF3A2 MED12 PDLIM5 KIF3A RPL17	3.01e-07	1247	63	13	27684187
Pubmed	Phosphoproteomic analysis of the developing mouse brain.	ABCF1 WAPL HSPH1 CTNNA2 SMAP2 GRSF1 KIF3A	3.21e-07	246	63	7	15345747
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	PPP4R3B SLK TCERG1 SLC4A1AP PRRC2C HSPH1 PSME1 HSPA4 TOP1 DNMT1 RPL17	3.25e-07	847	63	11	35235311
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	SLC4A1AP RBBP6 PRRC2C RSF1 BRD3 SPEN TOP1	3.68e-07	251	63	7	31076518
Pubmed	PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation.	CEP78 RBM27 RBBP6 PRRC2C HSPH1 HELZ HSPA4 GRSF1 TOP1 RPL17	3.74e-07	678	63	10	30209976
Pubmed	SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9.	ABCF1 PRRC2C RBM6 SPEN GRSF1 PRRC2B RPL17	4.42e-07	258	63	7	37794589
Pubmed	ATG5 is required for B cell polarization and presentation of particulate antigens.	MED6 TCERG1 RBM27 RBBP6 PRRC2C SARNP HSPA4 TOP1 PRRC2B DNMT1	5.07e-07	701	63	10	30196744
Pubmed	Insights into the ubiquitin-proteasome system of human embryonic stem cells.	MED6 ABCF1 TAF1 EIF3J SARNP TOP1 DNMT1	5.86e-07	269	63	7	29511261
Pubmed	The E3 ubiquitin ligase FBXL6 controls the quality of newly synthesized mitochondrial ribosomal proteins.	ABCF1 RBM27 RBBP6 HSPH1 HSPA4 GRSF1 TOP1 PDLIM5 RPL17	6.14e-07	547	63	9	37267103
Pubmed	mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.	RBM27 RBBP6 HSPH1 RBM6 MAP7 HSPA4 TOP1	6.62e-07	274	63	7	34244482
Pubmed	WWP2 ubiquitylates RNA polymerase II for DNA-PK-dependent transcription arrest and repair at DNA breaks.	ABCF1 PRRC2C HSPH1 RECQL5 PSME1 EIF3J TOP1 PRRC2B RPL17	1.61e-06	615	63	9	31048545
Pubmed	Calcium channels link the muscle-derived synapse organizer laminin β2 to Bassoon and CAST/Erc2 to organize presynaptic active zones.	CACNA1A NEFH PCLO	2.03e-06	14	63	3	21228161
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	ABCF1 TCERG1 RBM27 RBBP6 PRRC2C HSPH1 MAP7 SPEN TOP1 SF3A2 DNMT1 RPL17	2.29e-06	1257	63	12	36526897
Pubmed	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.	PPP4R3B ABCF1 RBBP6 PRRC2C HELZ GIGYF1 GRSF1 PRRC2B RPL17	2.70e-06	655	63	9	35819319
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	WAPL TCERG1 RBM27 RBBP6 ZMYND8 BRD3 SARNP TOP1 SF3A2 RPL17	2.77e-06	847	63	10	35850772
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	WAPL RBBP6 ZMYND8 SPEN TOP1 SF3A2 MED12	2.83e-06	341	63	7	32971831
Pubmed	Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells.	LIG1 SLC16A3 RBBP6 PRRC2C BRD4 BRD3 PSME1 SPEN DNMT1	3.05e-06	665	63	9	30457570
Pubmed	GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system.	TCERG1 HSPH1 MAP7 HSPA4 TOP1 RPL17	3.09e-06	221	63	6	29991511
Pubmed	Methylation of DNA Ligase 1 by G9a/GLP Recruits UHRF1 to Replicating DNA and Regulates DNA Methylation.	LIG1 RSF1 DNMT1	3.12e-06	16	63	3	28803780
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	CACNA1A NEFH MYCBP2 PCLO HSPH1 NGEF CTNNA2	3.17e-06	347	63	7	17114649
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TCERG1 MYCBP2 PRRC2C BRD4 HELZ GIGYF1 EIF3J MAP7 SMAP2 DNMT1	3.20e-06	861	63	10	36931259
Pubmed	Solution structure of RING finger-like domain of retinoblastoma-binding protein-6 (RBBP6) suggests it functions as a U-box.	RBBP6 HSPA4	3.23e-06	2	63	2	22130672
Pubmed	Coinhibition of topoisomerase 1 and BRD4-mediated pause release selectively kills pancreatic cancer via readthrough transcription.	BRD4 TOP1	3.23e-06	2	63	2	37831776
Pubmed	MED12 and BRD4 cooperate to sustain cancer growth upon loss of mediator kinase.	BRD4 MED12	3.23e-06	2	63	2	34910943
Pubmed	BRD3 and BRD4 BET Bromodomain Proteins Differentially Regulate Skeletal Myogenesis.	BRD4 BRD3	3.23e-06	2	63	2	28733670
Pubmed	A Mediator-cohesin axis controls heterochromatin domain formation.	WAPL MED12	3.23e-06	2	63	2	35136067
Pubmed	Recruitment of Brd3 and Brd4 to acetylated chromatin is essential for proinflammatory cytokine-induced matrix-degrading enzyme expression.	BRD4 BRD3	3.23e-06	2	63	2	30786900
Pubmed	BRD3/4 inhibition and FLT3-ligand deprivation target pathways that are essential for the survival of human MLL-AF9+ leukemic cells.	BRD4 BRD3	3.23e-06	2	63	2	29240787
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	ABCF1 PCLO NGEF CTNNA2 PRRC2B RPL17	3.98e-06	231	63	6	16452087
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	MYCBP2 RBBP6 PRRC2C MAP7 SPEN TOP1 PRRC2B	4.11e-06	361	63	7	26167880
Pubmed	Ovarian tumorB1-mediated heat shock transcription factor 1 deubiquitination is critical for glycolysis and development of endometriosis.	ABCF1 HSPH1 HELZ HSPA4 TOP1 PRRC2B	4.51e-06	236	63	6	36339263
Pubmed	BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors.	TCERG1 RBM27 BRD4 ZMYND8 SPEN	4.63e-06	134	63	5	25452129
Pubmed	TXLNA enhances TBK1 phosphorylation by suppressing PPM1B recruitment.	RBBP6 PRRC2C MAP7 SARNP TOP1	5.34e-06	138	63	5	37506885
Pubmed	Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics.	ABCF1 PRRC2C HSPH1 HSPA4 SF3A2 DNMT1 RPL17	6.16e-06	384	63	7	31059266
Pubmed	Characterizing ZC3H18, a Multi-domain Protein at the Interface of RNA Production and Destruction Decisions.	TCERG1 RBM27 RBBP6 PRRC2C ZMAT2 SPEN TOP1 SF3A2 RPL17	6.55e-06	731	63	9	29298432
Pubmed	Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.	ABCF1 SLC4A1AP PRRC2C HSPH1 MAP7 HSPA4 TOP1 PRRC2B	6.80e-06	551	63	8	34728620
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	SLK ABCF1 RBM27 PRRC2C HSPH1 MAP7	7.17e-06	256	63	6	33397691
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	WAPL RBM27 BRD4 HSPH1 ZMYND8 BRD3 TAF1	7.28e-06	394	63	7	27248496
Pubmed	Sox2 modulates the function of two distinct cell lineages in mouse skin.	CACNA1A NEFH PCLO	7.36e-06	21	63	3	23948231
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	BRD4 PCLO TSHZ1 BRD3 TAF1 ZHX2 DNMT1	7.77e-06	398	63	7	35016035
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	SLK ABCF1 WAPL TCERG1 PCLO HSPH1 SPEN HSPA4 GRSF1 TOP1 DNMT1 RPL17	8.22e-06	1425	63	12	30948266
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CACNA1A NEFH SLK MYCBP2 PRRC2C NGEF CTNNA2 PRRC2B KIF3A DNMT1	8.55e-06	963	63	10	28671696
Pubmed	In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.	MED6 ABCF1 PRRC2C HSPH1 CTNNA2 HSPA4 GRSF1 TOP1 DNMT1 RPL17	9.19e-06	971	63	10	33306668
Pubmed	Hsp110 is a bona fide chaperone using ATP to unfold stable misfolded polypeptides and reciprocally collaborate with Hsp70 to solubilize protein aggregates.	HSPH1 HSPA4	9.68e-06	3	63	2	23737532
Pubmed	Prevalence and pathogenesis of Barrett's esophagus in Luoyang, China.	HSPH1 HSPA4	9.68e-06	3	63	2	22901192
Pubmed	Comparative structure-function analysis of bromodomain and extraterminal motif (BET) proteins in a gene-complementation system.	BRD4 BRD3	9.68e-06	3	63	2	31792058
Pubmed	BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells.	BRD4 BRD3	9.68e-06	3	63	2	17934517
Pubmed	Bromodomain and Extraterminal (BET) Protein Inhibition Restores Redox Balance and Inhibits Myofibroblast Activation.	BRD4 BRD3	9.68e-06	3	63	2	31119153
Pubmed	Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration.	BRD4 BRD3	9.68e-06	3	63	2	24049186
Pubmed	BET Proteins Exhibit Transcriptional and Functional Opposition in the Epithelial-to-Mesenchymal Transition.	BRD4 BRD3	9.68e-06	3	63	2	29437854
Pubmed	Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets.	LIG1 RECQL5 RSF1 TOP1 DNMT1	1.00e-05	157	63	5	30686591
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	PPP4R3B LIG1 SLK ABCF1 HSPH1 PSME1 EIF3J MAP7 SARNP HSPA4 PDLIM5 RPL17	1.01e-05	1455	63	12	22863883
Pubmed	Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination.	BRD4 ZMYND8 BRD3 TAF1	1.08e-05	75	63	4	25593309
Pubmed	The HECT type ubiquitin ligase NEDL2 is degraded by anaphase-promoting complex/cyclosome (APC/C)-Cdh1, and its tight regulation maintains the metaphase to anaphase transition.	RBBP6 HSPH1 ZMYND8 EIF3J SF3A2 MED12	1.22e-05	281	63	6	24163370
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	ABCF1 PRRC2C ZMYND8 ZFHX3 SARNP SPEN TOP1 RPL17	1.34e-05	605	63	8	28977666
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	ZMYND8 GIGYF1 TAF1 ZHX2 SPEN HSPA4 PDLIM5 PRRC2B	1.39e-05	608	63	8	16713569
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	ABCF1 MYCBP2 PCLO HSPH1 ZFHX3 PSME1 HSPA4 TOP1 RPL17	1.44e-05	807	63	9	30575818
Pubmed	Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.	ABCF1 MYCBP2 HSPH1 ZMYND8 HSPA4 TOP1 SF3A2 KIF3A RPL17	1.47e-05	809	63	9	32129710
Pubmed	Expression of BET genes in testis of men with different spermatogenic impairments.	BRD4 BRD3	1.93e-05	4	63	2	22035730
Interaction	TERF2IP interactions	WAPL SLC16A3 TCERG1 SLC4A1AP RBM27 RBBP6 BRD4 ZMAT2 RECQL5 ZMYND8 RSF1 TAF1 SARNP SPEN HSPA4 TOP1 DNMT1	6.80e-13	552	63	17	int:TERF2IP
Interaction	NAA40 interactions	SLK ABCF1 WAPL TCERG1 RBM27 RBBP6 PRRC2C ZMAT2 HSPH1 ZMYND8 RSF1 HELZ PRR14L HSPA4 TOP1 PDLIM5 PRRC2B DNMT1 RPL17	7.34e-11	978	63	19	int:NAA40
Interaction	CEBPA interactions	PPP4R3B LIG1 MED6 ABCF1 TCERG1 MYCBP2 RBM27 PRRC2C BRD4 ZMAT2 HSPH1 ZMYND8 PSME1 SARNP SPEN HSPA4 TOP1 SF3A2 MED12 PRRC2B DNMT1	7.78e-11	1245	63	21	int:CEBPA
Interaction	CBX3 interactions	LIG1 WAPL SLC4A1AP RBM27 RBBP6 BRD4 ZMAT2 ZMYND8 RSF1 BRD3 SPEN TOP1 PDLIM5 PRRC2B DNMT1 RPL17	9.34e-11	646	63	16	int:CBX3
Interaction	SMC5 interactions	WAPL TCERG1 SLC4A1AP RBM27 RBBP6 PRRC2C BRD4 ZMAT2 RECQL5 ZMYND8 RSF1 RBM6 TAF1 SARNP SPEN TOP1 DNMT1 RPL17	8.89e-10	1000	63	18	int:SMC5
Interaction	HECTD1 interactions	MED6 ABCF1 CEP78 TCERG1 MYCBP2 RBM27 RBBP6 PRRC2C HSPH1 RBM6 TAF1 SARNP HSPA4 GRSF1 TOP1 MED12 DNMT1	5.38e-09	984	63	17	int:HECTD1
Interaction	THOC1 interactions	LIG1 SLC4A1AP RBM27 RBBP6 BRD4 RBM6 SARNP SPEN TOP1	1.77e-08	210	63	9	int:THOC1
Interaction	H2BC8 interactions	WAPL TCERG1 SLC4A1AP BRD4 ZMAT2 RECQL5 ZMYND8 RSF1 BRD3 SARNP SPEN TOP1 DNMT1	2.10e-08	576	63	13	int:H2BC8
Interaction	BAG2 interactions	LIG1 SLK RBM27 PRRC2C BRD4 BRD3 PRR14L SPEN SMAP2 HSPA4 SF3A2 MED12 PDLIM5	5.16e-08	622	63	13	int:BAG2
Interaction	SNRNP40 interactions	TCERG1 SLC4A1AP RBBP6 BRD4 RECQL5 RSF1 RBM6 ZFHX3 ZHX2 SPEN TOP1 SF3A2 MED12	6.81e-08	637	63	13	int:SNRNP40
Interaction	H3C1 interactions	WAPL PRRC2C BRD4 ZMAT2 RECQL5 ZMYND8 RSF1 ZFHX3 BRD3 PRR14L TAF1 SARNP SPEN TOP1 DNMT1	8.29e-08	901	63	15	int:H3C1
Interaction	NUP50 interactions	TCERG1 SLC4A1AP RBM27 RBBP6 BRD4 ZMAT2 RBM6 HELZ TAF1 SPEN	9.73e-08	341	63	10	int:NUP50
Interaction	MED4 interactions	MED6 SLK MYCBP2 RBM27 BRD4 ZMAT2 RECQL5 BRD3 MED12 PDLIM5 KIF3A	1.32e-07	450	63	11	int:MED4
Interaction	TOP1 interactions	LIG1 TCERG1 RBBP6 BRD4 ZMAT2 RECQL5 ZMYND8 RSF1 RBM6 BRD3 EIF3J GRSF1 TOP1	1.89e-07	696	63	13	int:TOP1
Interaction	POU5F1 interactions	ABCF1 WAPL TCERG1 RBM27 BRD4 HELZ ZFHX3 BRD3 TAF1 TOP1 SF3A2 PRRC2B	2.17e-07	584	63	12	int:POU5F1
Interaction	CELF1 interactions	TCERG1 RBM27 PRRC2C BRD4 RBM6 HELZ SMAP2 GRSF1 PRRC2B	2.64e-07	288	63	9	int:CELF1
Interaction	MECP2 interactions	ABCF1 TCERG1 MYCBP2 RBM27 RBBP6 BRD4 ZMYND8 RBM6 BRD3 UPF3A SARNP SPEN TOP1 SF3A2 MED12 DNMT1 RPL17	2.69e-07	1287	63	17	int:MECP2
Interaction	EFTUD2 interactions	SLK ABCF1 WAPL TCERG1 PRRC2C BRD4 HSPH1 RBM6 PSME1 EIF3J MAP7 HSPA4 GRSF1 TOP1 SF3A2 MED12 DNMT1 RPL17	2.72e-07	1449	63	18	int:EFTUD2
Interaction	CIT interactions	ABCF1 CLGN SLC16A3 TCERG1 RBM27 RBBP6 PRRC2C PCLO ZMYND8 RSF1 BRD3 PRR14L MAP7 SARNP GRSF1 TOP1 SF3A2 RPL17	2.75e-07	1450	63	18	int:CIT
Interaction	BRD3 interactions	ABCF1 TCERG1 RBBP6 BRD4 ZMYND8 RSF1 BRD3 TAF1 SARNP TOP1 DNMT1	3.35e-07	494	63	11	int:BRD3
Interaction	CPEB1 interactions	PRRC2C HSPH1 HELZ GIGYF1 SMAP2 HSPA4 PRRC2B	3.57e-07	146	63	7	int:CPEB1
Interaction	SIRT7 interactions	ABCF1 MYCBP2 PRRC2C BRD4 RSF1 RBM6 HELZ SPEN HSPA4 TOP1 MED12 PRRC2B DNMT1	4.06e-07	744	63	13	int:SIRT7
Interaction	SIRT6 interactions	PPP4R3B ABCF1 WAPL MYCBP2 RBM27 BRD4 RBM6 SARNP HSPA4 MED12 PDLIM5 RPL17	4.71e-07	628	63	12	int:SIRT6
Interaction	DNAJC8 interactions	SLK SLC4A1AP BRD4 HSPH1 SARNP SF3A2 PDLIM5 RPL17	5.75e-07	230	63	8	int:DNAJC8
Interaction	WWTR1 interactions	SLK WAPL TCERG1 MYCBP2 RBM27 PRRC2C BRD4 PDLIM5 PRRC2B DNMT1	6.92e-07	422	63	10	int:WWTR1
Interaction	YAP1 interactions	SLK WAPL TCERG1 RBBP6 PRRC2C BRD4 HSPH1 RECQL5 TAF1 SPEN HSPA4 MED12 PDLIM5 DNMT1 RPL17	1.01e-06	1095	63	15	int:YAP1
Interaction	ZNF330 interactions	SLC4A1AP ZMAT2 RECQL5 ZMYND8 RSF1 BRD3 TAF1 SARNP TOP1 DNMT1	1.14e-06	446	63	10	int:ZNF330
Interaction	SRRM1 interactions	WAPL BRD4 BRD3 UPF3A MAP7 GRSF1 TOP1 SF3A2 RPL17	1.28e-06	348	63	9	int:SRRM1
Interaction	SRPK2 interactions	MYCBP2 RBM27 RBBP6 PRRC2C RECQL5 BRD3 MAP7 SPEN GRSF1 TOP1 PRRC2B RPL17	1.89e-06	717	63	12	int:SRPK2
Interaction	CTNNBL1 interactions	BRD4 ZMYND8 RBM6 HSPA4 TOP1 SF3A2 KIF3A	2.67e-06	197	63	7	int:CTNNBL1
Interaction	HDAC4 interactions	CACNA1A TCERG1 PRRC2C NGEF GIGYF1 EIF3J TOP1 PDLIM5 PRRC2B KIF3A DNMT1 RPL17	2.78e-06	744	63	12	int:HDAC4
Interaction	NIPBL interactions	WAPL BRD4 ZMAT2 BRD3 TOP1 SF3A2 MED12	2.85e-06	199	63	7	int:NIPBL
Interaction	RBM39 interactions	TCERG1 SLC4A1AP PRRC2C BRD4 ZMAT2 HSPH1 RBM6 EIF3J SARNP HSPA4 GRSF1 TOP1 SF3A2 RPL17	3.11e-06	1042	63	14	int:RBM39
Interaction	NUP43 interactions	RBBP6 PRRC2C RECQL5 ZMYND8 RSF1 NGEF ZFHX3 ZHX2 SPEN TOP1 MED12	3.33e-06	625	63	11	int:NUP43
Interaction	MYCN interactions	ABCF1 RBBP6 PRRC2C ZMAT2 HSPH1 ZMYND8 RBM6 MAP7 SARNP HSPA4 GRSF1 TOP1 SF3A2 PRRC2B DNMT1 RPL17	3.40e-06	1373	63	16	int:MYCN
Interaction	DDX42 interactions	TCERG1 BRD4 RECQL5 NGEF RBM6 TOP1 SF3A2	3.82e-06	208	63	7	int:DDX42
Interaction	FUBP3 interactions	PRRC2C BRD4 RBM6 HELZ GIGYF1 SMAP2 GRSF1 PRRC2B	3.88e-06	297	63	8	int:FUBP3
Interaction	KCTD13 interactions	CACNA1A NEFH SLK ABCF1 PRRC2C PCLO HSPH1 NGEF CTNNA2 MAP7 HSPA4 TOP1 PDLIM5 PRRC2B KIF3A RPL17	4.13e-06	1394	63	16	int:KCTD13
Interaction	PRPF8 interactions	ABCF1 TCERG1 SLC4A1AP RBBP6 BRD4 RBM6 SPEN HSPA4 TOP1 SF3A2 MED12 RPL17	4.28e-06	776	63	12	int:PRPF8
Interaction	PNN interactions	RBBP6 BRD4 RBM6 BRD3 SARNP TRDN TOP1 SF3A2	4.39e-06	302	63	8	int:PNN
Interaction	NR2C2 interactions	PPP4R3B LIG1 ABCF1 WAPL TCERG1 RBM27 RBBP6 HSPH1 ZMYND8 HELZ HSPA4 GRSF1 TOP1 SF3A2 DNMT1 RPL17	4.49e-06	1403	63	16	int:NR2C2
Interaction	CHD4 interactions	SLK ABCF1 RBBP6 PRRC2C BRD4 ZMYND8 RSF1 ZFHX3 BRD3 SPEN TOP1 DNMT1 RPL17	5.32e-06	938	63	13	int:CHD4
Interaction	EHMT2 interactions	CACNA1A LIG1 MED6 BRD4 BRD3 MED12 PRRC2B DNMT1	5.98e-06	315	63	8	int:EHMT2
Interaction	RC3H2 interactions	CEP78 RBM27 RBBP6 PRRC2C HSPH1 HELZ SMAP2 HSPA4 GRSF1 PRRC2B RPL17	6.18e-06	667	63	11	int:RC3H2
Interaction	RC3H1 interactions	RBM27 PRRC2C HSPH1 HELZ MAP7 SMAP2 HSPA4 GRSF1 TOP1 PRRC2B RPL17	7.12e-06	677	63	11	int:RC3H1
Interaction	FXR2 interactions	PRRC2C BRD4 ZMAT2 ZMYND8 HELZ PSME1 MAP7 GRSF1 PRRC2B	7.20e-06	430	63	9	int:FXR2
Interaction	SF3B3 interactions	WAPL TCERG1 SLC4A1AP BRD4 RBM6 HELZ PRR14L MAP7 TOP1 SF3A2	8.35e-06	558	63	10	int:SF3B3
Interaction	SNRPC interactions	TCERG1 RBBP6 BRD4 ZMAT2 GIGYF1 SARNP SPEN TOP1 SF3A2	8.65e-06	440	63	9	int:SNRPC
Interaction	CPEB4 interactions	PRRC2C HELZ GIGYF1 TAF1 SMAP2 PRRC2B	9.22e-06	156	63	6	int:CPEB4
Interaction	BAP1 interactions	SLK ABCF1 TCERG1 MYCBP2 RBM27 PRRC2C HSPH1 PSME1 EIF3J MAP7 SARNP HSPA4 TOP1 PDLIM5 RPL17	9.44e-06	1314	63	15	int:BAP1
Interaction	AR interactions	MED6 WAPL MYCBP2 RBM27 BRD4 ZMYND8 ZFHX3 BRD3 TAF1 HSPA4 GRSF1 MED12 PRRC2B	9.73e-06	992	63	13	int:AR
Interaction	ATG16L1 interactions	MED6 CEP78 TCERG1 MYCBP2 RBM27 RBBP6 PRRC2C GIGYF1 SARNP HSPA4 TOP1 PRRC2B KIF3A DNMT1	1.08e-05	1161	63	14	int:ATG16L1
Interaction	RBMX interactions	LIG1 SLK BRD4 ZMYND8 PSME1 HSPA4 GRSF1 TOP1 SF3A2	1.26e-05	461	63	9	int:RBMX
Interaction	BTG3 interactions	CACNA1A WAPL MYCBP2 TAF1 KIF3A	1.38e-05	98	63	5	int:BTG3
Interaction	PPP1CB interactions	LIG1 SLK MYCBP2 BRD4 HSPH1 RBM6 PSME1 HSPA4 TOP1	1.44e-05	469	63	9	int:PPP1CB
Interaction	RBM8A interactions	SLK PRRC2C BRD4 ZMYND8 UPF3A EIF3J TOP1 SF3A2 RPL17	1.54e-05	473	63	9	int:RBM8A
Interaction	ATXN1 interactions	LIG1 SLC16A3 RBBP6 PRRC2C BRD4 BRD3 PSME1 ZHX2 SPEN HSPA4 SF3A2 PRRC2B DNMT1	1.59e-05	1039	63	13	int:ATXN1
Interaction	LSM14A interactions	TCERG1 MYCBP2 PRRC2C HELZ GIGYF1 SARNP PRRC2B	1.64e-05	260	63	7	int:LSM14A
Interaction	MED10 interactions	MED6 BRD4 RECQL5 BRD3 MED12	1.68e-05	102	63	5	int:MED10
Interaction	DDX23 interactions	SLK TCERG1 RBBP6 BRD4 RECQL5 RBM6 TAF1 TOP1 SF3A2	1.73e-05	480	63	9	int:DDX23
Interaction	SNRPA interactions	TCERG1 RBBP6 PRRC2C BRD4 ZMAT2 RBM6 GIGYF1 TOP1 SF3A2	1.79e-05	482	63	9	int:SNRPA
Interaction	RNF214 interactions	PRRC2C HELZ GIGYF1 SMAP2 PRRC2B	1.84e-05	104	63	5	int:RNF214
Interaction	MED23 interactions	MED6 BRD4 ZFHX3 BRD3 MAP7 SPEN MED12	1.90e-05	266	63	7	int:MED23
Interaction	LSM4 interactions	TCERG1 BRD4 ZMAT2 TOP1 SF3A2 PRRC2B	1.95e-05	178	63	6	int:LSM4
Interaction	POLR1G interactions	LIG1 SLC4A1AP BRD4 ZMAT2 ZMYND8 RSF1 BRD3 TAF1 TOP1	2.00e-05	489	63	9	int:POLR1G
Interaction	CHD3 interactions	TCERG1 PRRC2C BRD4 HSPH1 ZMYND8 ZFHX3 TAF1 PSME1 SARNP TOP1 RPL17	2.02e-05	757	63	11	int:CHD3
Interaction	BCAS2 interactions	BRD4 RBM6 BRD3 SPEN TOP1 SF3A2 PRRC2B	2.09e-05	270	63	7	int:BCAS2
Interaction	ZFP36 interactions	PRRC2C HELZ GIGYF1 SMAP2 HSPA4 PRRC2B	2.15e-05	181	63	6	int:ZFP36
Interaction	H3C3 interactions	WAPL BRD4 RECQL5 RSF1 BRD3 TAF1 SPEN TOP1 DNMT1	2.20e-05	495	63	9	int:H3C3
Interaction	TAF7 interactions	BRD4 RBM6 BRD3 TAF1 HSPA4	2.21e-05	108	63	5	int:TAF7
Interaction	ALG13 interactions	PRRC2C RBM6 HELZ SMAP2 GRSF1 PRRC2B	2.28e-05	183	63	6	int:ALG13
Interaction	CSNK1A1 interactions	LIG1 MYCBP2 BRD4 GIGYF1 EIF3J HSPA4 SF3A2 MED12	2.37e-05	381	63	8	int:CSNK1A1
Interaction	XRCC6 interactions	WAPL TCERG1 RBM27 RBBP6 BRD4 ZMYND8 ZFHX3 TAF1 SARNP SPEN TOP1 DNMT1	2.58e-05	928	63	12	int:XRCC6
Interaction	PABPN1 interactions	ABCF1 MYCBP2 BRD4 BRD3 HSPA4 TOP1	2.99e-05	192	63	6	int:PABPN1
Interaction	U2AF2 interactions	LIG1 TCERG1 BRD4 HSPH1 BRD3 PSME1 SARNP GRSF1 TOP1 SF3A2	3.15e-05	651	63	10	int:U2AF2
Interaction	TARDBP interactions	MED6 PRRC2C BRD4 HSPH1 HELZ HSPA4 GRSF1 TOP1 RPL17	3.24e-05	520	63	9	int:TARDBP
Interaction	CSNK2A1 interactions	LIG1 SLC4A1AP PRRC2C BRD4 HSPH1 ZMYND8 RSF1 BRD3 TAF1 EIF3J HSPA4 TOP1	3.45e-05	956	63	12	int:CSNK2A1
Interaction	DHX8 interactions	TCERG1 RBM27 RBBP6 RBM6 SPEN TOP1 RPL17	3.45e-05	292	63	7	int:DHX8
Interaction	PHIP interactions	BRD4 RSF1 HELZ ZFHX3 BRD3 TAF1	3.46e-05	197	63	6	int:PHIP
Interaction	TRIM28 interactions	PPP4R3B LIG1 SLK ABCF1 MYCBP2 BRD4 HSPH1 RECQL5 ZMYND8 RSF1 PSME1 TOP1 PDLIM5 DNMT1 RPL17	3.66e-05	1474	63	15	int:TRIM28
Interaction	MBD3 interactions	PPP4R3B ZBTB7C BRD4 ZMYND8 BRD3 SPEN DNMT1	3.68e-05	295	63	7	int:MBD3
Interaction	USP39 interactions	BRD4 HSPH1 BRD3 HSPA4 TOP1 SF3A2	3.87e-05	201	63	6	int:USP39
Interaction	SPDYE4 interactions	BRD4 BRD3 TAF1 DNMT1	3.96e-05	61	63	4	int:SPDYE4
Interaction	MED17 interactions	MED6 SLK BRD4 RECQL5 EIF3J MED12	3.98e-05	202	63	6	int:MED17
Interaction	EIF4ENIF1 interactions	RBBP6 PRRC2C HELZ GIGYF1 TAF1 SMAP2 PRRC2B	4.09e-05	300	63	7	int:EIF4ENIF1
Interaction	FMR1 interactions	MYCBP2 RBBP6 PRRC2C BRD4 ZMYND8 MAP7 GRSF1 PRRC2B DNMT1	4.11e-05	536	63	9	int:FMR1
Interaction	RABGAP1 interactions	SLK BRD4 HSPH1 TSKS RPL17	4.46e-05	125	63	5	int:RABGAP1
Interaction	SAP18 interactions	SLK RBBP6 BRD4 BRD3 TAF1 TOP1 SF3A2	4.55e-05	305	63	7	int:SAP18
Interaction	TCERG1 interactions	TCERG1 BRD4 RBM6 BRD3 TOP1 SF3A2	4.56e-05	207	63	6	int:TCERG1
Interaction	RBMS1 interactions	PRRC2C HELZ SARNP SMAP2 GRSF1 PRRC2B	4.56e-05	207	63	6	int:RBMS1
Interaction	SSRP1 interactions	TCERG1 RBBP6 BRD4 ZMAT2 ZMYND8 RSF1 BRD3 UPF3A GRSF1 TOP1	4.84e-05	685	63	10	int:SSRP1
Interaction	G3BP1 interactions	MYCBP2 PRRC2C BRD4 HELZ CTNNA2 EIF3J SMAP2 HSPA4 PDLIM5 PRRC2B RPL17	4.96e-05	835	63	11	int:G3BP1
Interaction	KLF16 interactions	PRRC2C HSPH1 RECQL5 TAF1 MAP7 ZHX2 HSPA4 PRRC2B	5.14e-05	425	63	8	int:KLF16
Interaction	RNF113A interactions	PPP4R3B ABCF1 RBBP6 PRRC2C HELZ GIGYF1 EIF3J GRSF1 PRRC2B RPL17	5.27e-05	692	63	10	int:RNF113A
Interaction	BRD2 interactions	LIG1 BRD4 ZMYND8 RSF1 BRD3 TAF1 TOP1 DNMT1	5.49e-05	429	63	8	int:BRD2
Interaction	AURKA interactions	LIG1 WAPL TCERG1 MYCBP2 RBM27 PRRC2C BRD4 RBM6 ZFHX3 HSPA4	5.53e-05	696	63	10	int:AURKA
Interaction	ZC3H7A interactions	PRRC2C HELZ GIGYF1 SMAP2 PDLIM5 PRRC2B	5.63e-05	215	63	6	int:ZC3H7A
Interaction	NIFK interactions	NEFH RBBP6 BRD4 ZMAT2 RECQL5 BRD3 GRSF1 RPL17	5.67e-05	431	63	8	int:NIFK
Interaction	RBBP6 interactions	RBBP6 BRD4 BRD3 PSME1 HSPA4 TOP1	5.77e-05	216	63	6	int:RBBP6
Interaction	GLDC interactions	RBM27 RBBP6 HSPH1 RBM6 MAP7 HSPA4 TOP1	6.28e-05	321	63	7	int:GLDC
Cytoband	17q25	SLC16A3 RECQL5	1.33e-03	39	63	2	17q25
Cytoband	22q12.2	NEFH PRR14L	2.92e-03	58	63	2	22q12.2
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZFHX3 TSHZ1 ZHX2	3.53e-06	15	37	3	529
GeneFamily	Heat shock 70kDa proteins	HSPH1 HSPA4	5.44e-04	17	37	2	583
GeneFamily	RNA binding motif containing	RBM27 RBM6 SPEN GRSF1	9.12e-04	213	37	4	725
GeneFamily	Cyclins\|Mediator complex	MED6 MED12	2.07e-03	33	37	2	1061
GeneFamily	Zinc fingers CCCH-type	RBM27 HELZ	2.32e-03	35	37	2	73
GeneFamily	PHD finger proteins	ZMYND8 RSF1	1.46e-02	90	37	2	88
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	CHL1 CACNA1A TCERG1 MYCBP2 PCLO ZMYND8 NGEF DCLK3 NAP1L3 ZFHX3 GIGYF1 CTNNA2 PRRC2B KIF3A	2.82e-07	1106	63	14	M39071
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	SLK MYCBP2 SLC4A1AP RBM27 HSPH1 RSF1 NAP1L3 UPF3A EIF3J FYB1 KIF3A	4.19e-07	656	63	11	M18979
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	SLK WAPL MYCBP2 PRRC2C ZMYND8 RBM6 HELZ ZFHX3 ZHX2 SPEN TOP1 PDLIM5	7.86e-07	856	63	12	M4500
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	SLK WAPL MYCBP2 PRRC2C ZMYND8 RBM6 HELZ ZHX2 SPEN	1.66e-06	466	63	9	M13522
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	PPP4R3B SLK WAPL MYCBP2 RBM27 RBBP6 RSF1 HELZ PSME1 SPEN FYB1 SMAP2 PRRC2B DNMT1 RPL17	1.82e-06	1492	63	15	M40023
Coexpression	FAN_OVARY_CL15_SMALL_ANTRAL_FOLLICLE_GRANULOSA_CELL	CHL1 MED6 RBBP6 FAM210A HSPH1 SARNP HSPA4 TOP1 PDLIM5 RPL17	2.96e-06	644	63	10	M41717
Coexpression	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN	TCERG1 MYCBP2 SLC4A1AP RBM27 HSPH1 ZMYND8 TOP1	4.04e-06	272	63	7	M15123
Coexpression	BERENJENO_TRANSFORMED_BY_RHOA_UP	LIG1 SLK TCERG1 ANKRD1 HSPH1 NGEF EIF3J HSPA4 DNMT1	6.38e-06	550	63	9	M16189
Coexpression	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	PPP4R3B MED6 WAPL SLC16A3 RBBP6 ANKRD1 RSF1 HSPA4 TOP1 DNMT1	7.99e-06	721	63	10	M10237
Coexpression	BERENJENO_TRANSFORMED_BY_RHOA_UP	LIG1 SLK TCERG1 ANKRD1 HSPH1 NGEF EIF3J HSPA4 DNMT1	8.62e-06	571	63	9	MM1100
Coexpression	GSE27786_LIN_NEG_VS_CD4_TCELL_DN	ZMAT2 RSF1 UPF3A PSME1 TSKS MED12	8.66e-06	200	63	6	M4773
Coexpression	GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN	MED6 SLK WAPL RBM27 TSHZ1 HSPA4	8.66e-06	200	63	6	M6993
Coexpression	MURARO_PANCREAS_BETA_CELL	CHL1 SLK CLGN MYCBP2 PCLO HSPH1 TSHZ1 PRRC2B RCAN2 KIF3A RPL17	1.41e-05	946	63	11	M39169
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	RBM27 PRRC2C BRD4 ZMYND8 ZFHX3 TAF1 EIF3J DNMT1	1.57e-05	467	63	8	M1347
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	RBM27 PRRC2C BRD4 ZMYND8 ZFHX3 TAF1 EIF3J DNMT1	2.03e-05	484	63	8	MM999
Coexpression	GSE3565_DUSP1_VS_WT_SPLENOCYTES_POST_LPS_INJECTION_UP	PPP4R3B NEFH BRD4 EIF3J RPL17	4.87e-05	165	63	5	M6332
Coexpression	MAYBURD_RESPONSE_TO_L663536_UP	BROX SF3A2 MED12	5.67e-05	31	63	3	M12002
Coexpression	TABULA_MURIS_SENIS_LIVER_ENDOTHELIAL_CELL_OF_HEPATIC_SINUSOID_AGEING	MYCBP2 PRRC2C BRD3 GIGYF1 PSME1 PRRC2B RPL17	6.40e-05	418	63	7	MM3752
Coexpression	MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS	RSF1 BRD3 SPEN DNMT1	6.63e-05	90	63	4	M39250
Coexpression	PUJANA_CHEK2_PCC_NETWORK	LIG1 MED6 TCERG1 RBBP6 PRRC2C HSPH1 HSPA4 TOP1 DNMT1	8.14e-05	761	63	9	M11961
Coexpression	GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP	LIG1 ZBTB7C ZFHX3 TAF1 SMAP2	9.49e-05	190	63	5	M4674
Coexpression	PUJANA_ATM_PCC_NETWORK	MED6 TCERG1 RBBP6 PRRC2C RBM6 TAF1 PSME1 ZHX2 HSPA4 TOP1 DNMT1 RPL17	1.04e-04	1394	63	12	M9585
Coexpression	GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP	MYCBP2 ZMYND8 BRD3 UPF3A ZHX2	1.18e-04	199	63	5	M7596
Coexpression	GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_UP	NEFH WAPL TCERG1 HSPH1 TOP1	1.18e-04	199	63	5	M5607
Coexpression	GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP	MYCBP2 PCLO ANKRD1 HSPH1 EIF3J	1.21e-04	200	63	5	M9358
Coexpression	GSE27786_ERYTHROBLAST_VS_MONO_MAC_DN	MYCBP2 TSHZ1 BRD3 UPF3A TSKS	1.21e-04	200	63	5	M4878
Coexpression	GSE20715_0H_VS_6H_OZONE_LUNG_DN	TCERG1 BRD4 SPEN TOP1 RCAN2	1.21e-04	200	63	5	M4365
Coexpression	ENK_UV_RESPONSE_KERATINOCYTE_DN	TCERG1 ZMYND8 RBM6 UPF3A EIF3J GRSF1 DNMT1	1.53e-04	481	63	7	M3898
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HDA2	CHL1 CACNA1A MYCBP2 NAP1L3 ZFHX3 CTNNA2 RCAN2	2.27e-04	513	63	7	M39069
Coexpression	KAYO_AGING_MUSCLE_DN	RBBP6 ZMYND8 TOP1 MED12	2.29e-04	124	63	4	M17261
Coexpression	BUSSLINGER_DUODENAL_IMMUNE_CELLS	MYCBP2 PRRC2C HELZ PSME1 FYB1 SMAP2 PRRC2B DNMT1 RPL17	3.13e-04	911	63	9	M40038
Coexpression	GSE12963_UNINF_VS_ENV_AND_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_UP	ZMYND8 HELZ GIGYF1 FYB1	3.17e-04	135	63	4	M447
Coexpression	WANG_TUMOR_INVASIVENESS_UP	SLK ABCF1 BRD4 HSPH1 BRD3 HSPA4	3.20e-04	384	63	6	M1865
Coexpression	UDAYAKUMAR_MED1_TARGETS_UP	SLK SLC16A3 GRSF1 SF3A2	3.26e-04	136	63	4	M3909
Coexpression	DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_IMMATURE_NEURONS	CLGN PCLO PRRC2B KIF3A	3.64e-04	140	63	4	M39288
Coexpression	IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP	PSME1 PDLIM5	3.69e-04	12	63	2	M5071
Coexpression	WANG_TUMOR_INVASIVENESS_UP	SLK ABCF1 BRD4 HSPH1 BRD3 HSPA4	4.08e-04	402	63	6	MM1248
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	ABCF1 WAPL TCERG1 RBM27 PRRC2C PCLO HSPH1 RSF1 RBM6 MAP7 ZHX2 HSPA4 GRSF1 TOP1 DNMT1	3.20e-11	532	63	15	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	PPP4R3B LIG1 MED6 ABCF1 WAPL TCERG1 SLC4A1AP RBM27 RBBP6 BRD4 HSPH1 RSF1 ZFHX3 HSPA4 GRSF1 TOP1 DNMT1	9.12e-08	1257	63	17	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5	ABCF1 TCERG1 PCLO HSPH1 RSF1 ZHX2 HSPA4 TOP1	1.56e-07	204	63	8	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	PPP4R3B LIG1 MED6 ABCF1 WAPL TCERG1 SLC4A1AP RBM27 RBBP6 BRD4 HSPH1 RSF1 ZFHX3 HSPA4 GRSF1 TOP1 DNMT1	7.55e-07	1459	63	17	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000	PPP4R3B ABCF1 TCERG1 PRRC2C HSPH1 ZMYND8 RBM6 HELZ ZFHX3 TSHZ1 BRD3 SARNP SF3A2	9.23e-07	843	63	13	gudmap_developingGonad_e11.5_testes_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000	ABCF1 CEP78 SLC16A3 TCERG1 PCLO HSPH1 RSF1 EIF3J MAP7 ZHX2 HSPA4 TOP1 SF3A2 PDLIM5	9.34e-07	991	63	14	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1	ABCF1 WAPL TCERG1 PRRC2C ZMAT2 HSPH1 RSF1 RBM6 HSPA4 TOP1	1.13e-06	469	63	10	Facebase_RNAseq_e8.5_Floor Plate_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#4	TCERG1 HSPH1 RSF1 MAP7 HSPA4 TOP1	1.82e-06	124	63	6	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500_K4
CoexpressionAtlas	DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000	ABCF1 TCERG1 PRRC2C HSPH1 ZMYND8 RBM6 HELZ TSHZ1 SARNP SF3A2	1.93e-06	498	63	10	gudmap_developingGonad_e11.5_testes_k5_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	CACNA1A ABCF1 TCERG1 SLC4A1AP RBBP6 PCLO HSPH1 PRR14L UPF3A HSPA4 TOP1 KIF3A	5.06e-06	831	63	12	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	CACNA1A ABCF1 SLC4A1AP RBM27 RBBP6 PCLO HSPH1 GRSF1	5.51e-06	328	63	8	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2
CoexpressionAtlas	DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000	ABCF1 TCERG1 HSPH1 ZMYND8 RBM6 TSHZ1 BRD3 SARNP PDLIM5	2.62e-05	533	63	9	gudmap_developingGonad_e11.5_testes and mesonephros_k5_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000	CACNA1A ABCF1 SLC4A1AP RBM27 RBBP6 PCLO HSPH1 MAP7 FYB1 HSPA4 GRSF1 TOP1	2.72e-05	983	63	12	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500	SLC16A3 TCERG1 HSPH1 RSF1 EIF3J MAP7 HSPA4 TOP1	1.05e-04	496	63	8	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	CACNA1A ABCF1 SLC4A1AP RBM27 RBBP6 PCLO HSPH1 HSPA4 GRSF1	1.26e-04	654	63	9	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	CACNA1A ABCF1 TCERG1 RBBP6 PCLO HSPH1 EIF3J MAP7 HSPA4 TOP1 KIF3A	1.41e-04	989	63	11	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_1000	PPP4R3B ABCF1 TCERG1 HSPH1 ZMYND8 RBM6 TSHZ1 BRD3 SARNP PDLIM5	1.76e-04	844	63	10	gudmap_developingGonad_e11.5_testes and mesonephros_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_MaxArch_2500_K3	CACNA1A PPP4R3B MED6 WAPL BRD4 HSPH1 RSF1 ZFHX3 SARNP HSPA4 TOP1 KIF3A	2.72e-04	1252	63	12	facebase_RNAseq_e10.5_MaxArch_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	ABCF1 TCERG1 RBBP6 HSPA4 TOP1 KIF3A	3.17e-04	311	63	6	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	PPP4R3B ABCF1 SLC4A1AP RBBP6 PRR14L UPF3A HSPA4 TOP1 KIF3A	4.65e-04	780	63	9	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
CoexpressionAtlas	facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500	LIG1 ABCF1 CEP78 SLC16A3 TCERG1 HSPH1 RSF1 EIF3J MAP7 SARNP HSPA4 TOP1	5.27e-04	1347	63	12	facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500
CoexpressionAtlas	facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1	LIG1 ABCF1 CEP78 SLC16A3 TCERG1 HSPH1 RSF1 EIF3J SARNP HSPA4 TOP1	5.70e-04	1164	63	11	facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1
CoexpressionAtlas	facebase_RNAseq_e8.5_FloorPlate_2500_K3	LIG1 MED6 ABCF1 CEP78 SLC16A3 TCERG1 BRD4 HSPH1 RSF1 EIF3J HSPA4 TOP1	6.17e-04	1371	63	12	facebase_RNAseq_e8.5_FloorPlate_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000	WAPL SLC16A3 PRRC2C PCLO ZMYND8 RSF1 RBM6 CTNNA2 MAP7 SMAP2	6.45e-04	994	63	10	Facebase_RNAseq_e8.5_Floor Plate_1000
CoexpressionAtlas	DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#3_top-relative-expression-ranked_1000	PPP4R3B SLC16A3 ZMYND8 RBM6 BRD3 SARNP	7.06e-04	362	63	6	gudmap_developingGonad_e18.5_testes_1000_k3
ToppCell	(00)_Basal-(2)_GFP_FOXI1\|(00)_Basal / shred by cell type by condition	RBM27 PRRC2C BRD4 HSPH1 RSF1 FYB1 RPL17	1.34e-08	199	63	7	19674e1eaeb51e4196d847cb62aa437c852951d3
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-ventral_progenitors_and_neurons_1\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	MYCBP2 PCLO NGEF NAP1L3 ZFHX3 RCAN2	3.60e-07	197	63	6	4961f66606f08e399508fd6cabca588e7ab406a8
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	NEFH RBBP6 PRRC2C RSF1 EIF3J DNMT1	3.60e-07	197	63	6	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	facs-Heart-RA-18m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WAPL MYCBP2 GIGYF1 SMAP2 SF3A2	5.35e-06	178	63	5	b505e2550860e777535ee95f29c936242fd607f1
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	TCERG1 PRRC2C HSPH1 HELZ HSPA4	7.92e-06	193	63	5	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_satellite_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC16A3 PRRC2C ANKRD1 RCAN2 RPL17	7.92e-06	193	63	5	1aa3ab528605dc7b2fec46e759c9d1ee93d59b11
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1A MYCBP2 PRRC2C PCLO TSHZ1	8.33e-06	195	63	5	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1A MYCBP2 PRRC2C PCLO TSHZ1	8.33e-06	195	63	5	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	RBBP6 PRRC2C BRD4 HSPH1 RSF1	9.19e-06	199	63	5	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	PCLO NAP1L3 ZFHX3 CTNNA2 KIF3A	9.19e-06	199	63	5	5de2a32bc2e9c752eb19a013b1807949153728fc
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	RBBP6 PRRC2C BRD4 HSPH1 RSF1	9.19e-06	199	63	5	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	(01)_IL1RL1+-(2)_GFP_FOXI1\|(01)_IL1RL1+ / shred by cell type by condition	RBBP6 PRRC2C BRD4 HSPH1 RSF1	9.19e-06	199	63	5	a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	MYCBP2 RBBP6 PRRC2C SMAP2 TOP1	9.41e-06	200	63	5	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	VE\|World / Condition, Cell_class and T cell subcluster	MYCBP2 PRRC2C PSME1 SMAP2 TOP1	9.41e-06	200	63	5	8ae7cb81de3ffac5acdf3466d4b516d80cac95d3
ToppCell	LV-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	ANKRD1 TRDN PDLIM5 RCAN2	3.47e-05	130	63	4	a3e12984fb61311e49cc76c59f74f4dffc48faa1
ToppCell	(08)_Brush+PNEC-(2)_GFP_FOXI1\|(08)_Brush+PNEC / shred by cell type by condition	RBBP6 PRRC2C BRD4 RSF1	4.39e-05	138	63	4	817e3f639604ea95adae01e8685ffaa2e0aff7a8
ToppCell	5'-Adult-Appendix-Epithelial-Tuft-related-Tuft\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NEFH ZFHX3 CTNNA2 FYB1	7.06e-05	156	63	4	58b9520fce6e259b36c3d59e82b712f5e7729e3e
ToppCell	COVID-19-Heart-CM_+_Macrophage\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ANKRD1 TRDN PDLIM5 RCAN2	9.85e-05	170	63	4	3f15242a1d3e4e9871d9170b2ef05842fb609c29
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-hematologic-hematopoietic_progenitor-hematopoietic_stem_cell\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CLGN PCLO NAP1L3 MAP7	9.85e-05	170	63	4	5bb577e2c4bd275fbe4ee23ff8c007b2fcb90e56
ToppCell	COVID-19-Heart-CM_+_Macrophage\|Heart / Disease (COVID-19 only), tissue and cell type	ANKRD1 FYB1 TRDN RCAN2	9.85e-05	170	63	4	4232fe937909f93d3736988c707b8f95ce993398
ToppCell	facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-skeletal_muscle_satellite_cell\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCLO ANKRD1 RCAN2 RPL17	1.08e-04	174	63	4	f230d23618a6487f2664efb2c677e0a4559e2bf4
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-hematologic-hematopoietic_progenitor\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CLGN PCLO NAP1L3 MAP7	1.08e-04	174	63	4	66df78280f657978c4a568010ae7d7943869af90
ToppCell	COVID-19-Heart-VSMC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1A ZBTB7C ZFHX3 RCAN2	1.10e-04	175	63	4	1125f0d3a5b2388fa77a820dea0288e824d84a82
ToppCell	droplet-Lung-1m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l9\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NEFH MAP7 SMAP2 RPL17	1.10e-04	175	63	4	849d8b09b19c10433d1a6a7c75e1f4e08b550954
ToppCell	COVID-19-Heart-CM_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ANKRD1 TRDN PDLIM5 RCAN2	1.13e-04	176	63	4	9df7a124ebafb0087da0cda133a394275d7bed81
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NEFH LIG1 MED12 DNMT1	1.15e-04	177	63	4	f10f77130dbb2c0ad1b436ceb4fb1deac2b0267c
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7\|TCGA-Colorectal / Sample_Type by Project: Shred V9	ZMAT2 HSPH1 ZMYND8 TOP1	1.18e-04	178	63	4	edc76b8f15056ec1c9a1c61a048b6331a92592d6
ToppCell	COVID-19-Heart-VSMC\|Heart / Disease (COVID-19 only), tissue and cell type	CACNA1A ZBTB7C ZFHX3 RCAN2	1.20e-04	179	63	4	a69ad6912b5c10bb9f9d800f724c792341e9bab1
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ANKRD1 TRDN PDLIM5 RCAN2	1.25e-04	181	63	4	719eb532453ab7cd7893726885bc75d74a10b21e
ToppCell	pdx-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	CHL1 ZBTB7C ZMYND8 CTNNA2	1.28e-04	182	63	4	7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee
ToppCell	COVID-19-Heart-CM_3\|Heart / Disease (COVID-19 only), tissue and cell type	ANKRD1 TRDN PDLIM5 RCAN2	1.28e-04	182	63	4	287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
ToppCell	wk_20-22-Mesenchymal-Chondrocyte-intermediate_chondrocyte\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	CHL1 LIG1 SLK ZFHX3	1.31e-04	183	63	4	1464b5c4425e8776c4aeb4d2b560481d4bf13931
ToppCell	facs-Heart-RA-18m-Mesenchymal-atrial_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANKRD1 TRDN PDLIM5 RCAN2	1.34e-04	184	63	4	72b42dfca7e9c0257f11d8242531e843271871a7
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	ANKRD1 TRDN PDLIM5 RCAN2	1.34e-04	184	63	4	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	facs-Heart-RA-18m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANKRD1 TRDN PDLIM5 RCAN2	1.34e-04	184	63	4	c6f4537ae8b6e8fde1be17df14629b7b49b4997c
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SLC16A3 HSPH1 FYB1 SMAP2	1.34e-04	184	63	4	d7f348aa8901d819c68da20728b9238407bcdca9
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANKRD1 TRDN PDLIM5 RCAN2	1.36e-04	185	63	4	9ef66bf63ed728cbf3044520a2a1625a9d5863a4
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ANKRD1 TRDN PDLIM5 RCAN2	1.36e-04	185	63	4	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	facs-Large_Intestine-Proximal-24m-Epithelial-enteroendocrine_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1A PCLO CTNNA2 RCAN2	1.36e-04	185	63	4	2a8104f610fa5ce618f8105521616722462a0d42
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYCBP2 HSPH1 SMAP2 HSPA4	1.36e-04	185	63	4	e913c64f9b4873443d88dce270f0b7b6d1b4cbce
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	ANKRD1 TRDN PDLIM5 RCAN2	1.36e-04	185	63	4	6baccb26f999145e51b91d94315bf8d4655bef31
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANKRD1 TRDN PDLIM5 RCAN2	1.36e-04	185	63	4	2148b78db2afaf29b01d604d314d6061179e2663
ToppCell	droplet-Mammary_Gland-nan-3m\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPH1 ZHX2 FYB1 RPL17	1.36e-04	185	63	4	02a2cbae9238c6c1e80b9a52a575e3b22f0eebb4
ToppCell	droplet-Bladder-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WAPL MYCBP2 PRRC2C TOP1	1.42e-04	187	63	4	663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCell	ILEUM-non-inflamed-(5)_Plasma-(5)_IgG_plasma_cells\|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	PRRC2C RBM6 TAF1 RPL17	1.45e-04	188	63	4	2156f1bc849ff1cb09ae296d13bedd913ae6b43b
ToppCell	droplet-Tongue-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RBM27 PRRC2C BRD4 TOP1	1.45e-04	188	63	4	d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd
ToppCell	COVID-19_Severe-HSPC\|COVID-19_Severe / disease group, cell group and cell class	CLGN PCLO NAP1L3 MAP7	1.48e-04	189	63	4	96015439971e2e5b8d6294ca5a6b873c7774e925
ToppCell	COVID-19_Severe-HSPC\|World / disease group, cell group and cell class	CLGN PCLO NAP1L3 MAP7	1.48e-04	189	63	4	555c0b13f1508b9e3712b36d77144e73e828bc76
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	ANKRD1 TRDN PDLIM5 RCAN2	1.48e-04	189	63	4	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	CHL1 PCLO NGEF ZFHX3	1.51e-04	190	63	4	6e92c78799f34b31d098854503c796edb0dc7f80
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	ANKRD1 TRDN PDLIM5 RCAN2	1.51e-04	190	63	4	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CACNA1A CEP78 HSPA4 RPL17	1.51e-04	190	63	4	600b9674197f743dea1d19d3df0fc993b6e6aa25
ToppCell	droplet-Spleen-nan-18m-Lymphocytic-immature_NKT_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEFH LIG1 CLGN DNMT1	1.51e-04	190	63	4	b99271d139c8d01e20feb95d99f79c9b2756b4cb
ToppCell	5'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZFHX3 CTNNA2 MAP7 FYB1	1.54e-04	191	63	4	54f07e4de61735051498846afb44b1798bed8144
ToppCell	Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	CHL1 MYCBP2 GIGYF1 KIF3A	1.54e-04	191	63	4	5d24022cec293bc8d9e978ae99a109e660bb8f83
ToppCell	Entopeduncular-Neuronal-Inhibitory\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	CHL1 MYCBP2 GIGYF1 KIF3A	1.54e-04	191	63	4	73dae4cdea86aec62393ad7303dc7375a6b3fc86
ToppCell	LA-03._Atrial_Cardiomyocyte\|LA / Chamber and Cluster_Paper	ANKRD1 TRDN PDLIM5 RCAN2	1.54e-04	191	63	4	5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZBTB7C ZFHX3 PDLIM5 RCAN2	1.54e-04	191	63	4	239c1e68eb1cbe3e137a99fbd6eeb8d64c919ffd
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC-NK_cell\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CACNA1A CEP78 HSPA4 RPL17	1.57e-04	192	63	4	c5f77c2103841505d13e09173549811312ef2f01
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CACNA1A CEP78 HSPA4 RPL17	1.57e-04	192	63	4	e981162f387a31111c0ae8355dbe9db5785c4838
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	TCERG1 HSPH1 HELZ HSPA4	1.57e-04	192	63	4	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	wk_15-18-Epithelial-PNS-FGFBP2+_Neural_progenitor\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CLGN RBM27 PCLO CTNNA2	1.57e-04	192	63	4	ab54d4bfc61ef7e3d765afe6e4a6d7011a301ecd
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|LV / Chamber and Cluster_Paper	ANKRD1 TRDN PDLIM5 RCAN2	1.57e-04	192	63	4	ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	PRRC2C BRD4 GIGYF1 PRRC2B	1.57e-04	192	63	4	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CACNA1A CEP78 HSPA4 RPL17	1.57e-04	192	63	4	3b0a52e4e77ae4539a034dcb419773b8e2aa5d51
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	ANKRD1 TRDN PDLIM5 RCAN2	1.60e-04	193	63	4	dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ABCF1 SARNP TRDN DNMT1	1.64e-04	194	63	4	40c6e17e9e48d4fa6da3a0a1066c4c6565a1e096
ToppCell	Neuron-Postmitotic-Inhibitory_Neuron-MGE2\|World / Primary Cells by Cluster	CHL1 PCLO RCAN2 KIF3A	1.64e-04	194	63	4	b42fd64b0fb95434a9e4e6586f31d26114a4074b
ToppCell	Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10\|World / Primary Cells by Cluster	CHL1 PCLO RCAN2 KIF3A	1.64e-04	194	63	4	81e7bc6516ab8d02ccd1c76a56a3533b788c27c8
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	ANKRD1 TRDN PDLIM5 RCAN2	1.64e-04	194	63	4	c3535f7cc0076653c72db582047cff053c322397
ToppCell	COVID-19-Heart-CM_1\|Heart / Disease (COVID-19 only), tissue and cell type	ANKRD1 TRDN PDLIM5 RCAN2	1.67e-04	195	63	4	f1ef50331eda8f1239dba6ea970df4eaccf032f1
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	ANKRD1 TRDN PDLIM5 RCAN2	1.67e-04	195	63	4	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WAPL MYCBP2 PRRC2C TRDN	1.67e-04	195	63	4	5c86fddd6d0530beecf45ea5ba6b823123847696
ToppCell	ASK452\|World / Donor, Lineage and Cell class of Lung cells from Dropseq	PRRC2C ANKRD1 HSPH1 TOP1	1.67e-04	195	63	4	7efd9d3a3f5e7dfe9698a4143ce4a0f9bf3a862c
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid\|BALF-PFMC / Compartment, severity and other cell annotations on 10x 3' data (130k)	FYB1 SMAP2 HSPA4 RPL17	1.70e-04	196	63	4	6361c37b0292ba9e5bf485a4809d2b0cd894c26e
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 PCLO CTNNA2 RCAN2	1.70e-04	196	63	4	36b4f08fc038dfde6343ff0869e1a027d882adb5
ToppCell	droplet-Limb_Muscle-nan-24m-Mesenchymal-skeletal_muscle_satellite_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC16A3 ANKRD1 RCAN2 RPL17	1.77e-04	198	63	4	d5e91d1057e71b6a336eec95e44b2e7fe6b2c6ef
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	MYCBP2 RBBP6 BRD4 RSF1	1.77e-04	198	63	4	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 CTNNA2 PDLIM5 RCAN2	1.77e-04	198	63	4	7b9c7ce5d6b7df8db85943b65da1a2c202a8bb53
ToppCell	10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	LIG1 PSME1 SF3A2 DNMT1	1.80e-04	199	63	4	5478b78349b5d8d57f30bb650dcbd5fdb84283d6
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	PRRC2C BRD4 PCLO RSF1	1.80e-04	199	63	4	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 CTNNA2 PDLIM5 RCAN2	1.80e-04	199	63	4	b4824d3683a4e3025b8e74a0f1755b331b2a0ba7
ToppCell	(05)_Secretory-(2)_GFP_FOXI1\|(05)_Secretory / shred by cell type by condition	RBM27 PRRC2C BRD4 RSF1	1.80e-04	199	63	4	d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	RBBP6 HSPH1 SMAP2 HSPA4	1.80e-04	199	63	4	f3cc3cda38f78d1d12d865df339d93c5fecf19f2
ToppCell	(02)_MMP9/10+-(2)_GFP_FOXI1\|(02)_MMP9/10+ / shred by cell type by condition	RBM27 BRD4 RSF1 RPL17	1.80e-04	199	63	4	18a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	PRRC2C BRD4 HSPH1 RSF1	1.80e-04	199	63	4	53ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	RBBP6 HSPH1 SMAP2 HSPA4	1.80e-04	199	63	4	c3c73c9404a73133bfad1f9ced292f5e508ef767
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DCLK3 ZFHX3 PDLIM5 RCAN2	1.80e-04	199	63	4	f1723cfd6fbb8c8903a3b167872ec8523e3be250
ToppCell	Striatum-Neuronal\|Striatum / BrainAtlas - Mouse McCarroll V32	NEFH MYCBP2 PCLO KIF3A	1.84e-04	200	63	4	c888fd487990cad482a4ca47601cdebc0ca3f3ce
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal\|2m / Sample Type, Dataset, Time_group, and Cell type.	PCLO NAP1L3 RCAN2 KIF3A	1.84e-04	200	63	4	60b86c4a4e247b2673d31b085b440a6e574393bb
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate\|2m / Sample Type, Dataset, Time_group, and Cell type.	CHL1 CTNNA2 PRRC2B KIF3A	1.84e-04	200	63	4	2a635694844ddabcd98462c5636a6f41a3f08a46
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Cortical_neuron\|2m / Sample Type, Dataset, Time_group, and Cell type.	PCLO NAP1L3 RCAN2 KIF3A	1.84e-04	200	63	4	db2dbd31dd02c0d1c1070ed5548ce949227e4775
Drug	AC1L9O0B	LIG1 TOP1	7.54e-06	2	63	2	CID000423843
Drug	Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A	SLC16A3 MYCBP2 RBBP6 PRRC2C PCLO SPEN	9.85e-06	178	63	6	3998_DN
Drug	Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A	SLC16A3 MYCBP2 PRRC2C BRD3 SPEN PDLIM5	1.02e-05	179	63	6	4585_DN
Drug	C75; Down 200; 10uM; PC3; HT_HG-U133A	RECQL5 ZMYND8 TSKS FYB1 SF3A2 KIF3A	1.47e-05	191	63	6	6399_DN
Drug	Hydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; HL60; HT_HG-U133A	CACNA1A SLC16A3 RECQL5 ZMYND8 TAF1 MAP7	1.61e-05	194	63	6	2430_DN
Drug	Erythromycin [114-07-8]; Down 200; 5.4uM; PC3; HG-U133A	MED6 RBBP6 HSPH1 ZMYND8 HSPA4 PDLIM5	1.65e-05	195	63	6	1928_DN
Drug	Chlorhexidine [55-56-1]; Down 200; 8uM; PC3; HG-U133A	LIG1 SLC16A3 RECQL5 ZHX2 PDLIM5 PRRC2B	1.65e-05	195	63	6	1942_DN
Drug	Methylprednisolone, 6-alpha [83-43-2]; Down 200; 10.6uM; HL60; HG-U133A	MED6 HSPH1 RECQL5 RSF1 MED12 PRRC2B	1.70e-05	196	63	6	1567_DN
Drug	Sulfadoxine [2447-57-6]; Down 200; 12.8uM; MCF7; HT_HG-U133A	SLC16A3 ZMYND8 TAF1 HSPA4 MED12 PRRC2B	1.70e-05	196	63	6	3547_DN
Drug	Glutethimide, para-amino [125-84-8]; Down 200; 17.2uM; HL60; HT_HG-U133A	ZMYND8 UPF3A MAP7 ZHX2 FYB1 HSPA4	1.70e-05	196	63	6	2390_DN
Drug	Flunixin meglumine [42461-84-7]; Down 200; 8.2uM; MCF7; HT_HG-U133A	PPP4R3B MED6 SLC4A1AP UPF3A PRRC2B KIF3A	1.75e-05	197	63	6	3411_DN
Drug	ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A	CACNA1A SLC16A3 PRR14L TAF1 MAP7 HSPA4	1.91e-05	200	63	6	5931_DN
Drug	radicicol	CACNA1A TCERG1 RSF1 ZHX2 HSPA4 TOP1	2.08e-05	203	63	6	CID000005033
Drug	methyl methanesulfonate	PPP4R3B LIG1 BRD4 RECQL5 TOP1 PDLIM5 DNMT1	6.46e-05	364	63	7	CID000004156
Drug	17-DMAG; Up 200; 0.1uM; HL60; HT_HG-U133A	PPP4R3B HSPH1 RECQL5 ZFHX3 HSPA4	1.21e-04	174	63	5	2673_UP
Drug	17-DMAG; Up 200; 0.1uM; MCF7; HT_HG-U133A	PPP4R3B MED6 HSPH1 RECQL5 HSPA4	1.28e-04	176	63	5	1638_UP
Drug	17-AAG; Up 200; 1uM; HL60; HT_HG-U133A	PPP4R3B HSPH1 RECQL5 HSPA4 PDLIM5	1.31e-04	177	63	5	2678_UP
Drug	ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA	MYCBP2 RBBP6 PRRC2C BRD4 SPEN	1.31e-04	177	63	5	985_DN
Drug	17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA	PPP4R3B SLC16A3 HSPH1 ZMYND8 HSPA4	1.34e-04	178	63	5	916_UP
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	MED6 WAPL ZMYND8 MAP7 ZHX2	1.53e-04	183	63	5	7498_DN
Drug	Sulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A	PRRC2C BRD4 SPEN HSPA4 KIF3A	1.61e-04	185	63	5	1673_DN
Drug	CTK8G2960	CACNA1A TCERG1 HSPH1 RSF1 HSPA4	1.65e-04	186	63	5	CID005361912
Drug	Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A	SLK RBBP6 ZMYND8 HELZ PRRC2B	1.69e-04	187	63	5	4989_DN
Drug	Nifuroxazide [965-52-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A	SLC16A3 PRR14L HSPA4 PDLIM5 PRRC2B	1.74e-04	188	63	5	4835_DN
Drug	17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A	HSPH1 ZMYND8 TAF1 TSKS MED12	1.78e-04	189	63	5	6966_UP
Drug	Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A	ANKRD1 PRR14L TAF1 SPEN PDLIM5	1.82e-04	190	63	5	4322_DN
Drug	LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A_EA	PPP4R3B SLC16A3 BRD4 HSPH1 HSPA4	1.82e-04	190	63	5	1016_DN
Drug	Butylparaben [94-26-8]; Down 200; 20.6uM; PC3; HT_HG-U133A	PPP4R3B BRD4 RECQL5 TAF1 PRRC2B	1.87e-04	191	63	5	4647_DN
Drug	Terfenadine [50679-08-8]; Down 200; 8.4uM; MCF7; HT_HG-U133A	ZMYND8 PRR14L HSPA4 GRSF1 KIF3A	1.87e-04	191	63	5	2227_DN
Drug	Cyanocobalamin [68-19-9]; Down 200; 3uM; MCF7; HT_HG-U133A	PPP4R3B MED6 PRRC2C ZMYND8 SF3A2	1.91e-04	192	63	5	3252_DN
Drug	chromomycin A3	CACNA1A TCERG1 HSPA4 TOP1	1.92e-04	103	63	4	CID000656673
Drug	Lasalocid sodium salt [25999-20-6]; Down 200; 6.6uM; HL60; HT_HG-U133A	CLGN BRD4 RECQL5 ZMYND8 MAP7	2.01e-04	194	63	5	3021_DN
Drug	Dirithromycin [62013-04-1]; Down 200; 4.8uM; HL60; HG-U133A	LIG1 PRRC2C SF3A2 MED12 PRRC2B	2.01e-04	194	63	5	1712_DN
Drug	Halcinonide [3093-35-4]; Down 200; 8.8uM; HL60; HT_HG-U133A	MED6 CLGN ZMYND8 PRR14L PRRC2B	2.01e-04	194	63	5	2185_DN
Drug	Thioguanosine [85-31-4]; Down 200; 12.6uM; HL60; HT_HG-U133A	SLK SLC16A3 PRRC2C HELZ FYB1	2.01e-04	194	63	5	1264_DN
Drug	5186324; Up 200; 2uM; MCF7; HT_HG-U133A_EA	PPP4R3B SLC16A3 ZMYND8 FYB1 PDLIM5	2.06e-04	195	63	5	900_UP
Drug	Benzocaine [94-09-7]; Down 200; 24.2uM; PC3; HT_HG-U133A	PPP4R3B PCLO RECQL5 TAF1 MAP7	2.06e-04	195	63	5	4224_DN
Drug	Protriptyline hydrochloride [1225-55-4]; Down 200; 13.4uM; HL60; HT_HG-U133A	CACNA1A NEFH MED6 ZHX2 HSPA4	2.06e-04	195	63	5	3119_DN
Drug	7-OMEN	RECQL5 TOP1	2.09e-04	8	63	2	CID000051370
Drug	Beclomethasone dipropionate [5534-09-8]; Down 200; 7.6uM; PC3; HT_HG-U133A	CACNA1A RECQL5 ZFHX3 TAF1 FYB1	2.11e-04	196	63	5	4580_DN
Drug	Tranexamic acid [1197-18-8]; Down 200; 25.4uM; MCF7; HT_HG-U133A	SLK SLC16A3 PRR14L UPF3A SF3A2	2.11e-04	196	63	5	6238_DN
Drug	Pivmecillinam hydrochloride [32887-03-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A	RECQL5 TAF1 TSKS SF3A2 MED12	2.11e-04	196	63	5	6014_DN
Drug	Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; PC3; HG-U133A	SLC16A3 HSPH1 RECQL5 PDLIM5 KIF3A	2.11e-04	196	63	5	1927_DN
Drug	Sulconazole nitrate [61318-91-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A	PPP4R3B SLK RECQL5 HELZ MED12	2.16e-04	197	63	5	4998_DN
Drug	Diprophylline [479-18-5]; Up 200; 15.8uM; HL60; HT_HG-U133A	NEFH MED6 BRD4 ZMYND8 HSPA4	2.16e-04	197	63	5	1853_UP
Drug	rottlerin; Down 200; 10uM; MCF7; HT_HG-U133A_EA	PPP4R3B SLC16A3 RECQL5 HSPA4 PRRC2B	2.16e-04	197	63	5	825_DN
Drug	chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HG-U133A	SLC16A3 MYCBP2 TAF1 MED12 PDLIM5	2.21e-04	198	63	5	426_DN
Drug	Glafenine hydrochloride [65513-72-6]; Up 200; 9.8uM; PC3; HT_HG-U133A	SLK BRD4 RECQL5 ZMYND8 MAP7	2.21e-04	198	63	5	7257_UP
Drug	Midecamycin [35457-80-8]; Up 200; 5uM; HL60; HG-U133A	PRRC2C ZMYND8 PSME1 FYB1 PDLIM5	2.21e-04	198	63	5	2026_UP
Drug	Todralazine hydrochloride [3778-76-5]; Up 200; 14.8uM; PC3; HT_HG-U133A	SLK WAPL CLGN SLC16A3 ZFHX3	2.21e-04	198	63	5	1799_UP
Drug	Ronidazole [7681-76-7]; Down 200; 20uM; MCF7; HT_HG-U133A	MED6 WAPL RECQL5 ZMYND8 HSPA4	2.21e-04	198	63	5	3557_DN
Drug	Isopyrin hydrochloride [18342-39-7]; Down 200; 14.2uM; MCF7; HT_HG-U133A	PPP4R3B MED6 BRD4 ZMYND8 PRRC2B	2.26e-04	199	63	5	7233_DN
Drug	Cholecalciferol [67-97-0]; Down 200; 10.4uM; MCF7; HT_HG-U133A	MED6 CLGN RECQL5 BRD3 SF3A2	2.26e-04	199	63	5	5002_DN
Drug	Metanephrine hydrochloride DL [881-95-8]; Down 200; 17.2uM; PC3; HG-U133A	MED6 SLC16A3 HSPH1 PDLIM5 PRRC2B	2.26e-04	199	63	5	1933_DN
Drug	Articaine hydrochloride [23964-57-0]; Up 200; 12.4uM; PC3; HT_HG-U133A	PPP4R3B SLC16A3 RECQL5 TAF1 ZHX2	2.26e-04	199	63	5	7272_UP
Drug	Noscapine [128-62-1]; Up 200; 9.6uM; MCF7; HT_HG-U133A	PPP4R3B SLC16A3 RECQL5 TSKS FYB1	2.31e-04	200	63	5	7204_UP
Drug	5'-CG-3	CACNA1A ZHX2 DNMT1	2.47e-04	44	63	3	CID000482125
Disease	3- 4-hydroxyphenyl lactate measurement	SLC16A3 TRDN	9.06e-05	7	62	2	EFO_0021008
Disease	Childhood Medulloblastoma	BRD4 BRD3 DNMT1	1.03e-04	43	62	3	C0278510
Disease	Melanotic medulloblastoma	BRD4 BRD3 DNMT1	1.03e-04	43	62	3	C1275668
Disease	Medullomyoblastoma	BRD4 BRD3 DNMT1	1.03e-04	43	62	3	C0205833
Disease	Desmoplastic Medulloblastoma	BRD4 BRD3 DNMT1	1.03e-04	43	62	3	C0751291
Disease	Adult Medulloblastoma	BRD4 BRD3 DNMT1	1.03e-04	43	62	3	C0278876
Disease	Medulloblastoma	BRD4 BRD3 DNMT1	1.61e-04	50	62	3	C0025149
Disease	chronic kidney disease, Proteinuria	CACNA1A SLC16A3	2.36e-04	11	62	2	EFO_0003884, HP_0000093
Disease	blood chromium measurement	TSHZ1 TRDN	1.37e-03	26	62	2	EFO_0007579

Protein segments in the cluster

Peptide	Gene	Start	Entry
PDPLPKKEEEKKEEE	CACNA1A	1191	O00555
PEKKEEPDPLQDKSI	FAM210A	106	Q96ND0
EIIKEKEPPKQGKEK	ABCF1	206	Q8NE71
IKPPKKDLEDGEVPQ	BRD3	286	Q15059
EPTPKQKLKEEPDRE	DNMT1	251	P26358
EVEENKKSKAKEPPP	BRD4	556	O60885
KTKVPVVKEPEPEII	ANKRD1	101	Q15327
NPPKEEKKALEDEKP	CEP78	571	Q5JTW2
EKKALEDEKPEPKQN	CEP78	576	Q5JTW2
EEEDPKTSPKPKIIQ	RCAN2	171	Q14206
PEPKPLVQEKEEIKE	RBM27	86	Q9P2N5
KEIELPKEVPEKLPE	GRSF1	376	Q12849
PVKREVKVEPEKKDP	MAP7	371	Q14244
VKVEPEKKDPEKEPQ	MAP7	376	Q14244
EKKDPEKEPQKVANE	MAP7	381	Q14244
KKGPKEPIPEEQELD	GIGYF1	316	O75420
PKPKVEPPKEEQKNA	HSPA4	786	P34932
PKFPKEKIDPLEVEE	CHL1	131	O00533
RKKPKEPQPEVAAAE	SLC16A3	411	O15427
KKRLEEPEEPKVLTP	EIF3J	96	O75822
PPEAKKPKIKVVNVE	HSPH1	581	Q92598
LEKEPKTRPEENKPE	DCLK3	321	Q9C098
KKPLPEEKKLIPEEE	PCLO	1211	Q9Y6V0
EKKPLLEEKKPTPED	PCLO	1231	Q9Y6V0
VKPSSEEKPDKEPKP	FYB1	66	O15117
VEKEVKPPPKEKIEG	MED12	706	Q93074
EPVPVQKGEPKEVVK	PDLIM5	91	Q96HC4
KAVVAPVEKPKPEDD	PPP4R3B	726	Q5MIZ7
KQTPVPDKKEKDPFE	KIF3A	631	Q9Y496
TPEKKPTEPKQVDLE	HELZ	1296	P42694
EPPIKKAKEETPKTD	RBBP6	1056	Q7Z6E9
PEKEIPKKEEVKSPV	NEFH	816	P12036
KEEEKPQEVKVKEPP	NEFH	831	P12036
PQEVKVKEPPKKAEE	NEFH	836	P12036
VKEPPKKAEEEKAPA	NEFH	841	P12036
PKPKVEEKKEPAVEK	NEFH	876	P12036
APAKVEVKEDAKPKE	NEFH	916	P12036
EPSKPAEKKEAAPEK	NEFH	946	P12036
PEKKPLVKREKPEEF	CTNNA2	911	P26232
KPAVKKEVKEEEPGA	LIG1	236	P18858
KEPKEPSPKQDVVGK	ZMYND8	731	Q9ULU4
EKPLPENEEKKIIKE	RSF1	296	Q96T23
LDIPVPDPVKEKEKE	PSME1	61	Q06323
KPGEKPVPVDQTKKE	MED6	196	O75586
QTKKEAEPIPETVKP	MED6	206	O75586
PEQKEAEPEKRPKKV	PRR14L	1996	Q5THK1
DPGLPEEEEIKEKKP	RBM6	821	P78332
KEKKEIPVSIKKEPE	SLK	681	Q9H2G2
KPIELPVKEEEPPEK	SARNP	66	P82979
KPTQQKDDKEPQPVK	TAF1	971	P21675
KPEKGEEPTTEKPKE	UPF3A	286	Q9H1J1
EPAKVKPELLPEKEE	NGEF	26	Q8N5V2
SKEPIERPEEKPKKE	PRRC2C	956	Q9Y520
VVVKPEKTEKKDLPP	PRRC2C	1046	Q9Y520
EEESKEPPIKLPKII	MYCBP2	186	O75592
PKENPEVKAEEKEVP	NAP1L3	196	Q99457
KEVPKEIPEVKAEEK	NAP1L3	221	Q99457
PEVKEDPKEVPQVKA	NAP1L3	246	Q99457
IVPKPEEEVAQKKKI	RPL17	156	P18621
KEAPAQPAPEKVKVE	SF3A2	91	Q15428
PKPEEEVKPVKEPDI	BROX	386	Q5VW32
EVKPVKEPDIKPQKD	BROX	391	Q5VW32
IKPPKEIEDPNDKKP	CLGN	261	O14967
KGKDPKIEEFVPPDE	RECQL5	516	O94762
QLKSDPVDPDKEPEK	SPEN	2136	Q96T58
EPVPEKKLEPVVFEK	SMAP2	146	Q8WU79
EKIKEPIKEPSEEPL	TCERG1	471	O14776
FKPDIQEIPKKPKVE	WAPL	51	Q7Z5K2
IEDKEDKPPPRQKFI	PRRC2B	481	Q5JSZ5
EPEEKQEPEEKQKPE	TSKS	251	Q9UJT2
AKKVPKKPEEITPEN	ZHX2	196	Q9Y6X8
EVKPKPPQLQGKKEE	TRDN	506	Q13061
GKKEEKPEPQIKKEA	TRDN	516	Q13061
NRKIKEEEKEELPPP	ZBTB7C	286	A1YPR0
PKNKDKDKKVPEPDN	TOP1	176	P11387
SEEKKEPEKEKPPVA	TSHZ1	496	Q6ZSZ6
EEREKKDGKPVQPVK	ZMAT2	31	Q96NC0
DKDPAKESPKPEEQK	ZFHX3	3411	Q15911
KIVKPAEIPELKKTE	SLC4A1AP	576	Q9BWU0